9
Views
0
CrossRef citations to date
0
Altmetric
Review

Combinations of interleukin-2 with other treatment modalities

&
Pages 231-248 | Published online: 24 Feb 2005
 

Abstract

Single agent cytokines have demonstrated efficacy in human clinical trials. Some of these agents have been approved for the treatment of cancer and/or infectious diseases. The systemic effects of cytokines are complex and interwoven. Combination therapies will offer opportunities to manipulate the immune system selectively, as research successes provide mechanistic support. Novel delivery systems and toxicity lowering agents are likely further to advance this field. The impact of the application of the human genomics and bioinformatics data currently being generated should be evident over the next decade as they are applied clinically, and can be expected significantly to advance treatment of these serious diseases.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.